Cacao stearoyl-acyl carrier protein desaturase gene diversity for cocoa butter modification
Exploration of stearoyl-ACP desaturase (SAD) gene diversity in cacao to alter cocoa butter fatty acid composition. By leveraging natural genetic variants or engineering new gene variants, the work targets changes in melting point and crystallization behavior. The approach centers on characterizing SAD isoforms and their expression patterns to support breeding and quality improvement efforts.
Overview
The research focuses on exploring diversity within the stearoyl-acyl carrier protein (ACP) desaturase (SAD) gene family in cacao plants. By understanding the distinct biochemical activities of the eight SAD isoforms in the cacao genome, this study aims to modify cocoa butter physical properties such as melting point and crystallization characteristics. Leveraging natural genetic diversity or creating new gene variants could lead to cocoa butter with improved qualities for applications that require precise control over fat composition, such as chocolate manufacturing.
Technical specifications
Key features include:
- Identification of eight SAD gene isoforms in cacao, each hypothesized to have unique biochemical activities.
- Potential to modify cocoa butter fatty acid composition by influencing the stearoyl-ACP to oleoyl-ACP conversion process.
- Focus on exploring expression patterns of TcSAD1, TcSAD3, and TcSAD4, with possible applications in breeding programs for quality enhancement and disease resistance.
Technology readiness level
Currently at Technology Readiness Level 2, this research is at the early stages of experimental proof of concept. While genetic diversity in SAD genes has been identified, further validation and development are planned, including testing enzyme sequences and assessing resulting cocoa butter modifications.
About Penn State University
Penn State University is a comprehensive public land‑grant research university with a large multi‑campus footprint across Pennsylvania. Industry engages through a research and technology park adjacent to the flagship campus that houses corporate R&D, co‑located labs, and flexible collaboration space, as well as a statewide extension network that enables field testing, demonstration, and workforce reach. Integration with a major hospital system supports clinical translation, and an applied research laboratory fosters mission‑driven partnerships with government and industry sponsors. Research is supported by competitive federal funding from agencies such as NSF, NIH, DOE, USDA, DoD, and NASA. A dedicated technology transfer office manages IP, licensing, and startup formation to accelerate commercialization.
delivered to your inbox.